JENNA PANNEBECKER: Open Payments
NPI 1114799319 · CENTER LINE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 23 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $338 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 5 | $180 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| ABBVIE INC. | 4 | $82 |
| Lilly USA, LLC | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| UCB, Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Organon LLC | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| LEO Pharma Inc. | 1 | $15 |
Products named: NEMLUVIO, COSENTYX, RINVOQ, TALTZ, Sotyktu, SKYRIZI, Bimzelx, DUPIXENT.
Industry payments across MI — which companies pay providers there.
